AZN financial statements

The full income statement, balance sheet, and cash-flow statement for AstraZeneca PLC (AZN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2017-12 1.27B2018-12 1.27B2019-12 1.30B2020-12 1.31B2021-12 1.43B2022-12 1.56B2023-12 1.56B2024-12 1.56B2025-12 1.56B+23.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	58.7B YoY+8.6%	54.1B YoY+18.0%	45.8B YoY+3.3%	44.4B YoY+18.5%	37.4B YoY+40.6%
	48.1B YoY+9.7%	43.9B YoY+16.8%	37.5B YoY+17.5%	32.0B YoY+27.9%	25.0B YoY+17.2%
Cost of revenue	10.6B YoY+4.2%	10.2B YoY+23.5%	8.27B YoY-33.3%	12.4B YoY-0.4%	12.4B YoY+134.7%
Research & development	14.2B YoY+4.8%	13.6B YoY+24.2%	10.9B YoY+12.0%	9.76B YoY+0.3%	9.74B YoY+62.5%
Operating income	13.7B YoY+37.4%	10.0B YoY+22.1%	8.19B YoY+118.1%	3.76B YoY+255.8%	1.06B YoY-79.5%
Interest expense	1.69B YoY-2.8%	1.74B YoY+7.1%	1.63B YoY+20.8%	1.35B YoY+3.5%	1.30B YoY-0.5%
Pre-tax income	12.4B YoY+42.7%	8.69B YoY+26.0%	6.90B YoY+175.8%	2.50B YoY+1043.8%	-265M YoY-106.8%
Income tax	2.17B YoY+31.5%	1.65B YoY+75.9%	938M YoY+218.4%	-792M YoY-108.4%	-380M YoY-149.2%
	10.2B YoY+45.3%	7.04B YoY+18.1%	5.96B YoY+81.0%	3.29B YoY+2763.5%	115M YoY-96.3%
Net income to common	10.2B YoY+45.3%	7.04B YoY+18.1%	5.96B YoY+81.1%	3.29B YoY+2835.7%	112M YoY-96.5%
	$6.54 YoY+45.3%	$4.50 YoY+18.1%	$3.81 YoY+80.6%	$2.11 YoY+2537.5%	$0.08 YoY-96.7%
EPS (basic)	$6.60 YoY+45.4%	$4.54 YoY+18.2%	$3.84 YoY+81.1%	$2.12 YoY+2550.0%	$0.08 YoY-96.7%
	1.55B YoY+0.0%	1.55B YoY+0.1%	1.55B YoY+0.1%	1.55B YoY+9.2%	1.42B YoY+8.1%
	1.56B YoY-0.1%	1.56B YoY+0.1%	1.56B YoY+0.1%	1.56B YoY+9.3%	1.43B YoY+8.7%
Dividends per share	$3.13 YoY+5.4%	$2.97 YoY+2.4%	$2.90 YoY+0.0%	$2.90 YoY+3.6%	$2.80 YoY+0.0%
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	28.7B YoY+11.2%	25.8B YoY+3.1%	25.1B YoY+10.9%	22.6B YoY-13.9%	26.2B YoY+34.3%
Cash & equivalents	5.71B YoY+4.1%	5.49B YoY-6.0%	5.84B YoY-5.3%	6.17B YoY-2.6%	6.33B YoY-19.2%
Accounts receivable	15.2B YoY+17.0%	13.0B YoY+7.0%	12.1B YoY+15.3%	10.5B YoY+9.1%	9.64B YoY+37.3%
Inventory	6.56B YoY+24.0%	5.29B YoY-2.5%	5.42B YoY+15.4%	4.70B YoY-47.7%	8.98B YoY+123.2%
	114B YoY+9.6%	104B YoY+2.9%	101B YoY+4.8%	96.5B YoY-8.4%	105B YoY+57.9%
Property, plant & equipment	13.0B YoY+26.4%	10.3B YoY+9.0%	9.40B YoY+10.5%	8.51B YoY-7.4%	9.18B YoY+11.3%
Goodwill	21.2B YoY+1.0%	21.0B YoY+4.9%	20.0B YoY+1.2%	19.8B YoY-0.9%	20.0B YoY+68.8%
Total non-current assets	85.4B YoY+9.1%	78.2B YoY+2.8%	76.1B YoY+2.9%	73.9B YoY-6.6%	79.1B YoY+67.7%
Total current liabilities	30.6B YoY+9.9%	27.9B YoY-8.8%	30.5B YoY+16.2%	26.3B YoY+16.4%	22.6B YoY+11.3%
	65.4B YoY+3.5%	63.2B YoY+2.0%	62.0B YoY+4.3%	59.4B YoY-10.1%	66.1B YoY+29.3%
Long-term debt	24.7B YoY-6.8%	26.5B YoY+18.5%	22.4B YoY-2.6%	23.0B YoY-18.4%	28.1B YoY+60.7%
	48.7B YoY+19.3%	40.8B YoY+4.2%	39.1B YoY+5.7%	37.0B YoY-5.7%	39.3B YoY+151.4%
Total equity incl. non-controlling	48.7B YoY+19.2%	40.9B YoY+4.4%	39.2B YoY+5.7%	37.1B YoY-5.7%	39.3B YoY+151.2%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Cash from operations	14.6B YoY+22.9%	11.9B YoY+14.7%	10.3B YoY+5.5%	9.81B YoY+64.5%	5.96B YoY+24.3%
Acquisitions	0.00	0.00	0.00	0.00	0.00
Long-term debt issued	15.0M YoY-99.8%	6.49B YoY+70.1%	3.82B	0.00 YoY-100.0%	12.9B YoY+335.6%
Long-term debt repaid	2.03B YoY-56.4%	4.65B YoY-5.9%	4.94B YoY+288.8%	1.27B YoY-73.3%	4.76B YoY+195.8%
Common stock issued	40.0M YoY+5.3%	38.0M YoY+15.2%	33.0M YoY+13.8%	29.0M YoY+0.0%	29.0M YoY-3.3%
Common stock repurchased	0.00	0.00	0.00	0.00	0.00
Dividends paid	4.85B YoY+5.3%	4.60B YoY+2.6%	4.49B YoY+0.0%	4.49B YoY+15.5%	3.88B YoY+5.8%
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	287B YoY+40.2%	205B YoY-2.5%	210B YoY+8.6%	194B YoY+16.4%	166B YoY+26.6%
P/E	28.1× YoY-3.5%	29.1× YoY-54.4%	63.8× YoY-96.2%	1682.6× YoY+16.4%	1445.6× YoY+3362.2%
P/S	4.9× YoY+29.1%	3.8× YoY-20.1%	4.7× YoY-8.4%	5.2× YoY+16.4%	4.4× YoY-9.9%
P/B	5.9× YoY+17.5%	5.0× YoY-11.5%	5.7× YoY+15.1%	4.9× YoY+16.4%	4.2× YoY-49.6%
	3.6% YoY+3.6%	3.4% YoY+119.4%	1.6% YoY+2536.8%	0.06% YoY-14.1%	0.07% YoY-97.1%
	1.7% YoY-24.9%	2.3% YoY+5.3%	2.2% YoY+0.7%	2.1% YoY-11.0%	2.4% YoY-14.2%
Source filing	20-F	20-F	20-F	20-F	20-F

About this data

Source: AZN's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all AZN filings on SEC EDGAR → Not investment advice.